logo-loader
HealthPharma & Biotech
DiaMedica

DiaMedica adds stroke expert as vice president

DiaMedica (CVE:DMA) has added a stroke expert to its management structure.

Management.jpg
Dr Todd Verdoom will join as vice president of neuroscience.

DiaMedica (CVE:DMA) has added a stroke expert to its management structure.

Dr Todd Verdoom, who has 26 years’ worth of experience in the sector, including five with Bristol-Myers Squibb's stroke group, has joined as vice president of neuroscience.

Rick Pauls, president & chief executive of DiaMedica said: “His knowledge and experience in stroke will help DiaMedica as we focus our efforts on acute ischemic stroke."

Verdoorn said he is “very excited” about the prospects for DiaMedica’s lead compound, DM199, in neurological indications, particularly ischemic stroke.

Quick facts: DiaMedica

Price: $4.73

Market: TSX-V
Market Cap: $56.56 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

'May only be a matter of time' before Uranium price recovery with...

Mining Capital's Alastair Ford discusses the planned slow down in production from Kazatomprom (LON:KAP). The miner's looking to cut output from its Kazakh mines by around 20% through to 2021. He says that extends the timeframe of its previous production curtailment by a further year, and...

8 hours, 3 minutes ago

2 min read